Update: October 2022
13.1 Conventional regimens for drug-susceptible TB
Intensive phase
Weight (kg) |
Paediatric formulations | Adult formulations | |||
---|---|---|---|---|---|
HZR 50/150/75 mg |
E 100 mg |
E 400 mg |
H 100 mg |
EHZR 275/75/400/150 mg |
|
4-7 | 1 tab | 1 tab | − | − | − |
8-11 | 2 tab | 2 tab | − | − | − |
12-13 | 3 tab | 2 tab | − | − | − |
14-15 | 3 tab | 3 tab | − | − | − |
16-17 | 4 tab | 3 tab | − | − | − |
18-22 | 4 tab | − | 1 tab | − | − |
23-29 | − | − | − | 1 tab | 2 tab |
|
|||||
30-34 | − | − | − | − | 2 tab |
35-39 | − | − | − | − |
2½ tab |
40-54 | − | − | − | − | 3 tab |
55-70 | − | − | − | − | 4 tab |
> 70 | − | − | − | − | 4 tab |
For example:
-
A child weighing 9 kg takes 2 tablets of HZR (50 mg/150 mg/75 mg) + 2 tablets of E (100 mg) once daily.
-
A child weighing 20 kg takes 4 tablets of HZR (50 mg/150 mg/75 mg) + 1 tablet of E (400 mg) once daily.
Note: ethambutol is not routinely given to all children: see Chapter 9.
Continuation phase
Weight (kg) |
Paediatric formulation HR 50/75 mg |
Adult formulation HR 75/150 mg |
|||
4-7 | 1 tab | − | |||
8-11 | 2 tab | − | |||
12-14 | 3 tab | − | |||
15-21 | − | 2 tab | |||
22-29 | − | 3 tab | |||
|
|||||
30-34 | − | 2 tab | |||
35-39 | − | 3 tab | |||
40-54 | − | 3 tab | |||
55-70 | − | 4 tab | |||
> 70 | − | 4 tab |
TB drugs |
Daily dosing in patients < 30 kg |
Daily dosing in patients ≥ 30 kg |
---|---|---|
E |
15 to 25 mg/kg |
15 to 25 mg/kg |
H |
7 to 15 mg/kg |
4 to 6 mg/kg |
Z |
30 to 40 mg/kg |
20 to 30 mg/kg |
R |
10 to 20 mg/kg |
8 to 12 mg/kg |
13.2 2HPZ-Mfx/2HP-Mfx regimen for drug-susceptible TB
Weight (kg) |
HP 300/300 mg |
P 300 mg |
Z 400 mg |
Mfx 400 mg |
---|---|---|---|---|
40-49 |
1 tab |
3 tab |
4 tab |
1 tab |
50-64 |
1 tab |
3 tab |
4 tab |
1 tab |
≥ 65 |
1 tab |
3 tab |
5 tab |
1 tab |
TB drugs |
Daily dosing in patients < 40 kg |
Daily dosing in patients ≥ 40 kg |
---|---|---|
H |
– |
300 mg |
Z |
– |
1600 to 2000 mg |
P |
– |
1200 mg |
Mfx |
– |
400 mg |